Screener
Vaxcyte, Inc. PCVX Total Non-Current Assets
Total Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsNoncurrent.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
| Line item | March 31,2026 | December 31, 2025 |
|---|---|---|
| Long-term investments | 1,004,017 | 881,664 |
| Restricted cash | 1,466 | 1,466 |
| Other assets | 155,539 | 118,847 |
| Total noncurrent assets | 1,534,820 | 1,375,356 |
| Total assets | $3,348,308 | $3,002,717 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $63,060 | $70,904 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Vaxcyte, Inc.'s total non-current assets?
- Vaxcyte, Inc. (PCVX) reported total non-current assets of $1.53B in Q1 2026.
- How has Vaxcyte, Inc.'s total non-current assets changed year-over-year?
- Vaxcyte, Inc.'s total non-current assets decreased by 7.6% year-over-year, from $1.66B to $1.53B.
- What is the long-term trend for Vaxcyte, Inc.'s total non-current assets?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s total non-current assets has grown at a 224.5% compound annual growth rate (CAGR), from $3.82M to $1.38B.
- What does total non-current assets mean?
- All long-term assets with useful lives beyond one year — equivalent to total_non_current_assets.
Ask your AI about Vaxcyte, Inc.'s total non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude